433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC). (September 2015) - Oudard, S.; Benhamouda, N.; Escudier, B.; Ravel, P.; Kothari, D.; Mehmud, F.; Levionnois, E.; Sevin, E.; Negrier, S.; Barthelemy, P.; Berdah, J.F.; Ravaud, A.; et al.